甲状腺弥漫性[18F]AlF-NOTA-FAPI-04摄取在PET/CT成像中的临床意义
这项回顾性研究纳入38例18F-FAPI PET/CT显示甲状腺弥漫性摄取的患者,定量评估正常甲状腺摄取并比较正常与病变甲状腺的摄取差异。正常甲状腺SUVmax为7.09±3.83,左右叶摄取无显著不对称。弥漫性甲状腺摄取与桥本甲状腺炎、血清TSH水平、性别、年龄及免疫治疗均无显著相关性。
要点
- 正常甲状腺18F-FAPI摄取SUVmax为7.09±3.83,SUVmean为4.24±2.25,TBR为3.93±1.73。
- 左右甲状腺叶18F-FAPI摄取无显著不对称(SUVmax p=0.84,SUVmean p=0.98)。
- 桥本甲状腺炎、血清TSH水平与弥漫性甲状腺摄取程度无显著相关性(所有p>0.05)。
核心结论
- 甲状腺弥漫性18F-FAPI摄取可能与桥本甲状腺炎或血清TSH水平异常无显著关联。
- 由于正常甲状腺组织存在中度摄取,18F-FAPI PET/CT扫描上的病变可能难以检测。
研究设计与样本
- 回顾性研究,纳入38例符合入选标准的接受18F-FAPI PET/CT成像且显示甲状腺弥漫性摄取的患者。
主要发现
- 正常甲状腺的SUVmax、SUVmean和TBR分别为7.09±3.83、4.24±2.25和3.93±1.73。
- 左右甲状腺叶间18F-FAPI摄取无显著不对称:SUVmax右侧6.69±2.96 vs 左侧6.54±3.28(p=0.84);SUVmean右侧4.19±1.73 vs 左侧4.18±1.97(p=0.98)。
- 桥本甲状腺炎、血清TSH水平与弥漫性甲状腺摄取程度无显著相关性(SUVmax、SUVmean和TBR的p值均>0.05)。
- 性别、年龄、免疫治疗与弥漫性甲状腺摄取无关联(p>0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many patients undergoing [18F] AlF-NOTA-FAPI-04 (18F-FAPI) PET/CT demonstrated diffuse thyroid uptake. These findings created challenges for accurate interpretation due to the limited understanding of physiological and non-oncologic causes of diffuse 18F-FAPI uptake in the thyroid. This retrospective study examined patients who underwent 18F-FAPI PET/CT imaging with diffuse thyroid uptake. It quantitatively assessed normal thyroid uptake, compared 18F-FAPI uptake between normal and diseased thyroids, and explored potential associations with diffuse thyroid uptake. The study may improve the accuracy of 18F-FAPI PET/CT interpretation for thyroid and facilitate appropriate management of diffuse thyroid uptake on 18F-FAPI PET/CT. RESULTS: A total of 38 patients were included in this study based on the inclusion criteria. The mean SUVmax, SUVmean, and TBR of normal thyroid were 7.09 ± 3.83, 4.24 ± 2.25 and 3.93 ± 1.73, respectively. Quantitative analysis revealed no significant asymmetry in 18F-FAPI uptake between the right and left thyroid lobes (SUVmax: right 6.69 ± 2.96 vs. left 6.54 ± 3.28, p = 0.84; SUVmean: right 4.19 ± 1.73 vs. left 4.18 ± 1.97, p = 0.98), consistent with the diffuse uptake pattern observed. There was no significant correlation between Hashimoto thyroiditis, serum TSH levels, and the degree of diffuse thyroid uptake (all p > 0.05 for SUVmax, SUVmean, and TBR). Furthermore, no association was observed between sex, age, immunotherapy, and diffuse thyroid uptake (p > 0.05). CONCLUSIONS: Diffuse uptake of 18F-FAPI in the thyroid may not significantly relate to Hashimoto thyroiditis or abnormal serum TSH levels. Lesions on 18F-FAPI PET/CT scans might be hard to detect due to the moderate uptake in normal thyroid tissue.
引用
- Kou Y, Diao W, Cheng Z, et al. Clinical significance of diffuse [18F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging. EJNMMI Res. 2025. PMID: 40279069. doi:10.1186/s13550-025-01231-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。